DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy
Olaussen Ken A,
Popper Helmut H,
Le Chevalier Thierry,
IALT Bio Investigators
The New England journal of medicine (2006).
Adjuvant cisplatin-based chemotherapy improves survival among patients with completely resected non-small-cell lung cancer, but there is no validated clinical or biologic predictor of the benefit of chemotherapy.